Appropriate dosing of burosumab in tumor-induced osteomalacia

被引：3
作者：
Colangelo, Luciano [1 ]
Sonato, Chiara [1 ]
Riminucci, Mara [2 ]
Corsi, Alessandro [2 ]
Minisola, Salvatore [1 ]
机构：
[1] Sapienza Univ Rome, Dept Clin Internal Anesthesiol & Cardiovasc Sci, Rome, Italy
[2] Sapienza Univ Rome, Dept Mol Med, Rome, Italy
来源：
OSTEOPOROSIS INTERNATIONAL | 2022年 / 34卷 / 2期
关键词：
D O I：
10.1007/s00198-022-06617-2
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：421 / 421
页数：1
相关论文
共 5 条
  • [1] Long-term use of burosumab for the treatment of tumor-induced osteomalacia
    Crotti, C.
    Zucchi, F.
    Alfieri, C.
    Caporali, R.
    Varenna, M.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2023, 34 (01) : 201 - 206
  • [2] Burosumab for Tumor-Induced Osteomalacia: Not Enough of a Good Thing
    Hartley, Iris R.
    Collins, Michael T.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (12) : 2453 - 2454
  • [3] Interim Analysis of a Phase 2 Open-Label Trial Assessing Burosumab Efficacy and Safety in Patients With Tumor-Induced Osteomalacia
    Imanishi, Yasuo
    Ito, Nobuaki
    Rhee, Yumie
    Takeuchi, Yasuhiro
    Shin, Chan Soo
    Takahashi, Yutaka
    Onuma, Hiroki
    Kojima, Masahiro
    Kanematsu, Masanori
    Kanda, Hironori
    Seino, Yoshiki
    Fukumoto, Seiji
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (02) : 262 - 270
  • [4] A Randomized, Double-Blind, Placebo-Controlled, Phase 3 Trial Evaluating the Efficacy of Burosumab, an Anti-FGF23 Antibody, in Adults With X-Linked Hypophosphatemia: Week 24 Primary Analysis
    Insogna, Karl L.
    Briot, Karine
    Imel, Erik A.
    Kamenicky, Peter
    Ruppe, Mary D.
    Portale, Anthony A.
    Weber, Thomas
    Pitukcheewanont, Pisit
    Cheong, Hae Il
    de Beur, Suzanne Jan
    Imanishi, Yasuo
    Ito, Nobuaki
    Lachmann, Robin H.
    Tanaka, Hiroyuki
    Perwad, Farzana
    Zhang, Lin
    Chen, Chao-Yin
    Theodore-Oklota, Christina
    Mealiffe, Matt
    Martin, Javier San
    Carpenter, Thomas O.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2018, 33 (08) : 1383 - 1393
  • [5] Burosumab for the Treatment of Tumor-Induced Osteomalacia
    Jan de Beur, Suzanne M.
    Miller, Paul D.
    Weber, Thomas J.
    Peacock, Munro
    Insogna, Karl
    Kumar, Rajiv
    Rauch, Frank
    Luca, Diana
    Cimms, Tricia
    Roberts, Mary Scott
    San Martin, Javier
    Carpenter, Thomas O.
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 2021, 36 (04) : 627 - 635
1